San Antonio leaders push ‘City of Science’ vision for bioscience hub
San Antonio’s bioscience sector has grown dramatically in recent decades. But it hasn’t kept pace with the city’s…
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193,…